Rockwell Medical, Inc.
$0.94
▲
2.54%
2026-04-21 09:11:00
www.rockwellmed.com
NCM: RMTI
Explore Rockwell Medical, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$37.03 M
Current Price
$0.94
52W High / Low
$2.1 / $0.78
Stock P/E
—
Book Value
$0.94
Dividend Yield
—
ROCE
-9.86%
ROE
-15.28%
Face Value
—
EPS
$-0.15
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
157
Beta
1.71
Debt / Equity
33.73
Current Ratio
3.98
Quick Ratio
3.63
Forward P/E
13
Price / Sales
0.52
Enterprise Value
$23.33 M
EV / EBITDA
-9.33
EV / Revenue
0.34
Rating
Strong Buy
Target Price
$3
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Akebia Therapeutics, Inc. | $1.43 | — | $381.73 M | — | 11% | 64.49% | $4.08 / $1.14 | $0.12 |
| 2. | Aquestive Therapeutics, Inc. | $4.24 | — | $527.23 M | — | -62.98% | 178.61% | $7.55 / $2.12 | $-0.28 |
| 3. | Zoetis Inc. | $118.25 | 19.63 | $49.71 B | 1.64% | 27.18% | 65.99% | $172.23 / $113.29 | $7.84 |
| 4. | Shuttle Pharmaceuticals Holdings, Inc. | $0.99 | — | $5.7 M | — | -791.36% | -7.91% | $11.25 / $0.5 | $1.13 |
| 5. | Aurora Cannabis Inc. | $3.72 | — | $285.82 M | — | 1.34% | -15.51% | $9.33 / $4.29 | $6.8 |
| 6. | ANI Pharmaceuticals, Inc. | $81.73 | 23.13 | $1.81 B | 0.06% | 6.99% | 16.16% | $99.5 / $56.71 | $25.8 |
| 7. | Aytu BioPharma, Inc. | $2.58 | — | $27.69 M | — | 4.15% | -1.09% | $3.06 / $0.98 | $1.32 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 18.35 M | 15.93 M | 16.07 M | 18.91 M | 24.66 M | — |
| Operating Profit | -0.4 M | -1.58 M | -1.35 M | -1.36 M | -0.52 M | — |
| Net Profit | -0.55 M | -1.75 M | -1.49 M | -1.51 M | -0.76 M | — |
| EPS in Rs | -0.01 | -0.04 | -0.04 | -0.04 | -0.02 | 0.04 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 69.26 M | 101.49 M | 83.61 M | 72.81 M |
| Operating Profit | -4.69 M | 0.61 M | -6.67 M | -16.78 M |
| Net Profit | -5.31 M | -0.48 M | -8.44 M | -18.68 M |
| EPS in Rs | -0.13 | -0.01 | -0.21 | -0.47 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 57.15 M | 59.21 M | 52.17 M | 46.63 M |
| Total Liabilities | 20.16 M | 26.62 M | 30.88 M | 32.53 M |
| Equity | 36.98 M | 32.59 M | 21.29 M | 14.11 M |
| Current Assets | 38.16 M | 37.03 M | 28.77 M | 35.31 M |
| Current Liabilities | 9.58 M | 14.09 M | 16.64 M | 17.69 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -0.66 M | 4.2 M | -9.41 M | -16.93 M |
| Investing CF | -8.54 M | -4.87 M | -3.04 M | -2.4 M |
| Financing CF | 4.25 M | 7.35 M | 11.34 M | 16.15 M |
| Free CF | -1.2 M | 3.19 M | -9.7 M | -17.21 M |
| Capex | -0.54 M | -1.01 M | -0.28 M | -0.28 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | -31.76% | 21.38% | 14.84% | — |
| Earnings Growth % | -1007.08% | 94.31% | 54.82% | — |
| Profit Margin % | -7.67% | -0.47% | -10.09% | -25.65% |
| Operating Margin % | -6.77% | 0.6% | -7.98% | -23.05% |
| Gross Margin % | 16.89% | 17.23% | 10.41% | 5.6% |
| EBITDA Margin % | -2.88% | 2.91% | -5.61% | -22.2% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2022-05-13 | 1:0.0909091 |